- Home
- LUNG vs MCR Comparison
LUNG vs MCR Comparison
Compare LUNG & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- MCR
- Stock Information
- Founded
- LUNG 1995
- MCR 1989
- Country
- LUNG United States
- MCR United States
- Employees
- LUNG N/A
- MCR N/A
- Industry
- LUNG Industrial Specialties
- MCR Trusts Except Educational Religious and Charitable
- Sector
- LUNG Health Care
- MCR Finance
- Exchange
- LUNG Nasdaq
- MCR Nasdaq
- Market Cap
- LUNG 65.6M
- MCR 265.5M
- IPO Year
- LUNG 2020
- MCR N/A
- Fundamental
- Price
- LUNG $1.63
- MCR $6.57
- Analyst Decision
- LUNG Buy
- MCR
- Analyst Count
- LUNG 7
- MCR 0
- Target Price
- LUNG $7.66
- MCR N/A
- AVG Volume (30 Days)
- LUNG 574.6K
- MCR 66.7K
- Earning Date
- LUNG 10-29-2025
- MCR 01-01-0001
- Dividend Yield
- LUNG N/A
- MCR 8.52%
- EPS Growth
- LUNG N/A
- MCR N/A
- EPS
- LUNG N/A
- MCR 0.38
- Revenue
- LUNG $90,549,000.00
- MCR N/A
- Revenue This Year
- LUNG $10.30
- MCR N/A
- Revenue Next Year
- LUNG $14.72
- MCR N/A
- P/E Ratio
- LUNG N/A
- MCR $16.61
- Revenue Growth
- LUNG 18.24
- MCR N/A
- 52 Week Low
- LUNG $1.47
- MCR $5.63
- 52 Week High
- LUNG $9.37
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- LUNG 41.00
- MCR 73.43
- Support Level
- LUNG $1.60
- MCR $6.35
- Resistance Level
- LUNG $1.76
- MCR $6.43
- Average True Range (ATR)
- LUNG 0.14
- MCR 0.05
- MACD
- LUNG 0.03
- MCR 0.01
- Stochastic Oscillator
- LUNG 16.03
- MCR 86.96
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.